Acquisition / mergerFiled on BSE ·
Sagility Limited reports Q2 FY27 financial results and declares interim dividend
Sagility · IT - Services
What the filing says
- Approved unaudited standalone and consolidated financial results for quarter and six months ended 30 Sept 2026; consolidated revenue ₹2,032.10 crore, profit ₹284.21 crore
- Declared interim dividend of ₹0.15 per equity share for FY 2026-27, record date 30 Oct 2026, payout approx. ₹70.22 crore by 21 Nov 2026
- Acquired 100% equity of CareSeed LLC for USD 30 million; signed agreement to acquire Chirok Health LLC for USD 32.35 million, closing conditions pending as of 22 Oct 2026
Original filing
Board Meeting Outcome for Outcome Of Board Meeting Held On October 22, 2026
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Waaree Energies Ltd
Electrical Equipment
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Sagility
- Acquisition / mergerNotableSagility Limited acquires Chirok Health to expand provider-focused services
Other acquisition / merger filings this fortnight
- Acquisition / mergerSwelect EnergySwelect Energy Systems to acquire 100% shares of Sushma Solar Energy Pvt Ltd
- Acquisition / mergerUgro Capital LtdUGRO Capital Ltd announces NCLT hearing date for amalgamation scheme with Profectus
- Acquisition / mergerCyient LtdCyient Limited announces Q2 and H1 FY27 financial results and corporate updates
- Acquisition / mergerShyam Metalics & Energy LtdShyam Sel and Power Ltd seeks NCLT approval for scheme to amalgamate Shree Venkateshwara Electrocast Pvt Ltd
- Acquisition / mergerPetronet LNG LtdPetronet LNG signs binding term sheet with Gruner Renewable for CBG JV
- Acquisition / mergerJindal Stainless LtdJindal Stainless Limited approves Q2 FY27 financial results and merger scheme
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.